ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

Scrips' diabetes patient supply program is also a source of revenue growth as it now has enrolled 1,500 patients to date, a figure that has tripled since February of this year.

In a 3/4/15 PR, SCRC touted that it had enrolled 500 patients in the first couple months, an avg of 250/mo, and generated $100k in revenues from them. We have no idea what their costs are and how much net earnings this $100k is actually contributing. It may be awesome or it could be a money-loser like PIMD was.

So now, SCRC has apparently enrolled another 1,000 over the next 5-1/2 months, an avg of 182/mo. So enrollment is slowing, which isn't good.

And if 500 patients generated $100k, then 1,500 patients should generate $300k in revenues. Annualized, this represents $3.6M in revenues. Considering how much Main Ave revenues have fallen, $3.6M from PIMD may unfortunately be material now. So it will be important to find out from any forthcoming Q filings what the cost structure is and how much earnings this actually translates to...